OBGYN.net Conference CoverageFrom ISGE 2001 Congress - Chicago, Illinois, 2001
Click here for Audio/Video Version *requires RealPlayer - free download
Dr. Yap Lip Kee: “I’m Dr. Yap Lip Kee the incoming President for the ISGE. It’s a pleasure to be here in Chicago. We are looking at the newest things available to gynecologists, gynecology, and endoscopists. With me is Dr. James Daniell, one of the pioneers in the field and he plans to tell us a bit more about what is new.”
Dr. James Daniell: “Dr. Yap, thank you very much. It’s always a pleasure to get the chance to be interviewed for OBGYN.net because it gives a wide dissemination of information around the world. The things that I’ve seen from walking around the exhibits here today are interesting. There’s some old, there’s some new, there’s some borrowed, but there’s nothing blue here today. I think we’ve got about thirty-five exhibitors from many countries. One of the things that I saw that is most interesting is a new safer way to use bipolar electro-surgery. Everest Medical, which is located here in the states, is coming out with a new generator from England, which allows laparoscopic use of bipolar instrumentation with a system of bipolar that they call “PK” generation. This is really just bipolar energy delivered in an intermittent pulse mode so that there’s reduced thermo damage as your applying the electrosurgery. As you and I both know with laparoscopy, electricity can be very, very dangerous and anything that can reduce the risk for collateral damage with electricity, I think, will be a benefit for improved safety of surgery. We’ve also done some animal studies with this PK generator in our lab in Nashville, and we’ve been able to actually coagulate blood vessels as large as 5 mm laparoscopically in animal model, which I think is very impressive. I think this is one of the things at this meeting here of the ISGE that is very impressive in just coming on market here in the states and will be a good addition to the armamentarium for all laparoscopic surgeons that are dealing with large blood vessels during either hysterectomy or adnexal removal. Again, it’s my pleasure to sit and talk with you here briefly and to talk about this for OBGYN.net. Thank you.”
Dr. Yap Lip Kee: “Thank you, Jim, for the quick updates.”
Advancing obstetric and gynecologic surgery through robotic innovation
April 30th 2024Explore how robotic surgery revolutionizes obstetric and gynecologic procedures, offering enhanced precision, reduced complications, and improved patient outcomes, while also examining challenges and future prospects in the field.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Excessive gonadotropins in IVF: Effects on mosaicism and live birth
April 12th 2024A recent study revealed a correlation between high doses and prolonged duration of exogenous gonadotropin use during in vitro fertilization and increased embryonic mosaicism alongside diminished live birth rates, prompting reconsideration of dosage and duration protocols.
Read More
Maternal history linked to uterine fibroid risk in Black women
April 11th 2024Delve into the findings of a recent study revealing the heightened risk of developing uterine fibroids among Black women with a maternal history of the condition, shedding light on crucial implications for patient care and advocacy.
Read More